by MM360 Staff | Mar 14, 2026 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | Mar 14, 2026 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | Mar 14, 2026 | Publications
Ann Med. 2026 Dec;58(1):2641930. doi: 10.1080/07853890.2026.2641930. Epub 2026 Mar 12. ABSTRACT BACKGROUND: Elotuzumab, an anti-SLAMF7 monoclonal antibody for multiple myeloma (MM), lacks a comprehensive safety profile from meta-analysis. METHODS: We systematically...
by Marisa Wexler, MS | Mar 13, 2026 | Myeloma News
People with advanced pancreatic cancer who followed a ketogenic diet program administered by Virta Health while receiving chemotherapy tended to live longer than those treated with chemotherapy only, according to results from a small clinical trial. “Our randomized...
by Andrea Lobo | Mar 12, 2026 | Myeloma News
Inovio Pharmaceuticals and Akeso have entered into a clinical trial collaboration and supply agreement to evaluate a novel immunotherapy combining INO-5412 plus cadonilimab as a potential treatment for glioblastoma, an aggressive form of glioma. The Phase 2 INSIGhT...
